Safety of High-intensity Treatment with the Irreversible Monoamine Oxidase Inhibitor Tranylcypromine in Patients with Treatment-resistant Depression (vol 41, pg 252, 2008)

Research output: Contribution to specialist publicationCorrections (errata and retractions)peer-review

Contributors

Details

Original languageGerman
Pages39-39
Number of pages1
Volume42
Issue number1
JournalPharmacopsychiatry
Publication statusPublished - Jan 2009
Peer-reviewedYes
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical

External IDs

ORCID /0000-0002-2666-859X/work/149438758

Keywords